Center-Authored Papers

Filters: Author is Van Den Eeden, Stephen K  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, Fuchs CS, Petersen GM, Arslan AA, Bueno-de-Mesquita BH, Gross M, Helzlsouer K, Jacobs EJ et al..  2009.  Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer.. Nature genetics. 41(9):986-90. Abstract
Austin MA, Kuo E, Van Den Eeden SK, Mandelson MT, Brentnall TA, Kamineni A, Potter JD.  2013.  Family History of Diabetes and Pancreatic Cancer as Risk Factors for Pancreatic Cancer: The PACIFIC Study.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 22(10):1913-7. Abstract
B
Brinton LA, Cook MB, McCormack V, Johnson KC, Olsson H, Casagrande JT, Cooke R, Falk RT, Gapstur SM, Gaudet MM et al..  2014.  Anthropometric and Hormonal Risk Factors for Male Breast Cancer: Male Breast Cancer Pooling Project Results.. Journal of the National Cancer Institute. Abstract
C
Cook MB, Guénel P, Gapstur SM, van den Brandt PA, Michels KB, Casagrande JT, Cooke R, Van Den Eeden SK, Ewertz M, Falk RT et al..  2015.  Tobacco and alcohol in relation to male breast cancer: an analysis of the male breast cancer pooling project consortium.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 24(3):520-31. Abstract
H
Habel LA, Danforth KN, Quesenberry CP, Capra A, Van Den Eeden SK, Weiss NS, Ferrara A.  2013.  Cohort study of insulin glargine and risk of breast, prostate, and colorectal cancer among patients with diabetes.. Diabetes care. 36(12):3953-60. Abstract
K
Klein AP, Lindström S, Mendelsohn JB, Steplowski E, Arslan AA, Bueno-de-Mesquita BH, Fuchs CS, Gallinger S, Gross M, Helzlsouer K et al..  2013.  An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population.. PloS one. 8(9):e72311. Abstract
M
McDermott CL, Blough DK, Fedorenko CR, Arora NK, Zeliadt SB, Fairweather ME, Oakley-Girvan I, Van Den Eeden SK, Ramsey SD.  2012.  Complementary and alternative medicine use among newly diagnosed prostate cancer patients.. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 20(1):65-73. Abstract
P
Petersen GM, Amundadottir L, Fuchs CS, Kraft P, Stolzenberg-Solomon RZ, Jacobs KB, Arslan AA, Bueno-de-Mesquita BH, Gallinger S, Gross M et al..  2010.  A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33.. Nature genetics. 42(3):224-8. Abstract
R
Ramsey SD, Zeliadt SB, Blough DK, Fedorenko CR, Fairweather ME, McDermott CL, Penson DF, Van Den Eeden SK, Hamilton AS, Arora NK.  2012.  Complementary and alternative medicine use, patient-reported outcomes, and treatment satisfaction among men with localized prostate cancer.. Urology. 79(5):1034-41. Abstract
Ramsey SD, Zeliadt SB, Arora NK, Potosky AL, Blough DK, Hamilton AS, Van Den Eeden SK, Oakley-Girvan I, Penson DF.  2009.  Access to information sources and treatment considerations among men with local stage prostate cancer.. Urology. 74(3):509-15. Abstract
Ramsey SD, Zeliadt SB, Arora NK, Blough DK, Penson DF, Oakley-Girvan I, Hamilton AS, Van Den Eeden SK, Fedorenko CR, Potosky AL.  2010.  Unanticipated and underappreciated outcomes during management of local stage prostate cancer: a prospective survey.. The Journal of urology. 184(1):120-5. Abstract
T
Trabert B, Holt VL, Yu O, Van Den Eeden SK, Scholes D.  2011.  Population-based ectopic pregnancy trends, 1993-2007.. American journal of preventive medicine. 40(5):556-60. Abstract
W
Wang Z, Zhu B, Zhang M, Parikh H, Jia J, Chung CC, Sampson JN, Hoskins JW, Hutchinson A, Burdette L et al..  2014.  Imputation and subset based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33.. Human molecular genetics. 23(24):6616-33. Abstract
Z
Zeliadt SB, Ramsey SD, Van Den Eeden SK, Hamilton AS, Oakley-Girvan I, Penson DF, Fairweather ME, Arora NK, Potosky AL.  2010.  Patient recruitment methods to evaluate treatment decision making for localized prostate cancer.. American journal of clinical oncology. 33(4):381-6. Abstract